We are advising McKesson on the transaction

Davis Polk is advising McKesson Corporation on its acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) for approximately $2.49 billion in cash, which will represent approximately 70% ownership. Florida Cancer Specialists & Research Institute, LLC, which established Core Ventures, and Florida Cancer Specialist physicians will retain a minority interest in the company. The transaction is subject to customary closing conditions, including necessary regulatory clearances.

McKesson is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. McKesson’s teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments and others to deliver insights, products and services to help make quality care more accessible and affordable.

Florida Cancer Specialists & Research Institute (FCS) is a leading physician-owned community oncology practice. With over 250 physicians, 280 nurse practitioners and physician assistants and nearly 100 locations in its network, Florida Cancer Specialists is committed to providing world-class cancer care in community-based settings close to home. Core Ventures is engaged by Florida Cancer Specialists as its exclusive provider of non-clinical business and other administrative services. 

The Davis Polk corporate team includes partner Alan F. Denenberg, counsel Jason Bassetti and associate Michelle Zhang. Partner Frank J. Azzopardi is providing intellectual property advice. Partner Veronica M. Wissel and associate Mackenzie Bouverat are providing executive compensation advice. Partner Patrick E. Sigmon and associates Dov Sussman and Ryan Powers are providing tax advice. Counsel Julie E. Dechen is providing real estate advice. Members of the Davis Polk team are based Northern California and New York offices. 

Copy link to share post